INTERNATIONAL PATENT: ALIGOS THERAPEUTICS, INC. FILES APPLICATION FOR "METHODS AND COMPOSITIONS FOR TARGETING PD-L1"

GENEVA, Aug. 26 -- ALIGOS THERAPEUTICS, INC. (1 Corporate Drive, 2nd FloorSouth San Francisco, California 94080) filed a patent application (PCT/US2025/015528) for "METHODS AND COMPOSITIONS FOR TARGETING PD-L1" on Feb 12, 2025. With publication no. WO/2025/174835, the details related to the patent application was published on Aug 21, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WU, Tongfei (c/o Aligos Therapeutics, Inc.1 Corporate Drive, 2nd FloorSouth San Francisco, California 94080)

Abstract: The present disclosure related to compounds that can be useful as inhibitors of PD-1, PD-L1 ...